Skip to content

Testing how the Homoeopathic medicine Allium sativum (Garlic) Affects Heart Health in Male with Stage 1 High Blood Pressure

Evaluation of Autonomic Nervous System Modulation in Stage 1 Hypertensive Males Using Heart Rate Variability Following Homoeopathic Medicine Allium sativum Potencies (Q, 6C, 30C): A Randomized Controlled Interventional Study. - HRV-ASH

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/06/111585
Enrollment
120
Registered
2026-06-01
Start date
Unknown
Completion date
Unknown
Last updated
2026-06-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: I10- Essential (primary) hypertension

Interventions

Intervention1: Allium sativa Mother Tincture, Allium sativa 6C, Allium sativa 30C: Mother Tincture and Potencies are prepared according to the Homoeopathic Pharmacopoeia of India Control Intervention1

Sponsors

FATHER MULLER RESEARCH CENTER
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Male patients aged 35 to 75 years Hypertensive males were selected to minimize hormonal and physiological variability, providing a stable and measurable biological model suitable for detecting subtle physicochemical effects of high dilutions. Individuals of stage 1 hypertension according to American heart association

Exclusion criteria

Exclusion criteria: Diabetic patients and individuals with high BMI Subjects with history of myocardial infarction, arrythmia or recent surgery

Design outcomes

Primary

MeasureTime frame
Heart Rate VariabilityTimepoint: Patient will be in a relaxed supine position for 20mins before checking the first ECG for HRV. Then medicine will be given and ECG will be repeated after 24 hours.

Secondary

MeasureTime frame
NilTimepoint: Nil

Countries

India

Contacts

Public ContactDR SKANDHAN S KUMAR

FATHER MULLER HOMOEOPATHIC MEDICAL COLLEGE

skandanskumar@fathermuller.in7892401344

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Jun 29, 2026